Gürbüz, M. Et Al. 2022. Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group. Journal of Cancer Research and Clinical Oncology , vol.148, no.12 , 3547-3555.

Gürbüz, M., Kutlu, Y., Akkuş, E., KÖKSOY, E. B., Köse, N., Öven, B. B., ... Uluç, B. O.(2022). Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group. Journal of Cancer Research and Clinical Oncology , vol.148, no.12, 3547-3555.

Gürbüz, Mustafa Et Al. "Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group," Journal of Cancer Research and Clinical Oncology , vol.148, no.12, 3547-3555, 2022

Gürbüz, Mustafa Et Al. "Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group." Journal of Cancer Research and Clinical Oncology , vol.148, no.12, pp.3547-3555, 2022

Gürbüz, M. Et Al. (2022) . "Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group." Journal of Cancer Research and Clinical Oncology , vol.148, no.12, pp.3547-3555.

@article{article, author={Mustafa Gürbüz Et Al. }, title={Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group}, journal={Journal of Cancer Research and Clinical Oncology}, year=2022, pages={3547-3555} }